Cargando…
High Performance of SARS-Cov-2N Protein Antigen Chemiluminescence Immunoassay as Frontline Testing for Acute Phase COVID-19 Diagnosis: A Retrospective Cohort Study
Objectives: COVID-19 emerged and rapidly spread throughout the world. Testing strategies focussing on patients with COVID-19 require assays that are high-throughput, low-risk of infection, and with small sample volumes. Antigen surveillance can be used to identify exposure to pathogens and measure a...
Autores principales: | Deng, Qiaoling, Ye, Guangming, Pan, Yunbao, Xie, Wen, Yang, Gui, Li, Zhiqiang, Li, Yirong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317577/ https://www.ncbi.nlm.nih.gov/pubmed/34336884 http://dx.doi.org/10.3389/fmed.2021.676560 |
Ejemplares similares
-
Re: Profile of specific antibodies to SARS-CoV-2: The first report
por: Zeng, Zhikun, et al.
Publicado: (2020) -
Flow Injection Chemiluminescent Immunoassay for Carcinoembryonic Antigen Using Boronic Immunoaffinity Column
por: Ma, Xiaoling, et al.
Publicado: (2009) -
The Detection of SARS-CoV2 Antigen in Wastewater Using an Automated Chemiluminescence Enzyme Immunoassay
por: Thongpradit, Supranee, et al.
Publicado: (2022) -
Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation
por: Ye, Guangming, et al.
Publicado: (2020) -
Serodiagnosis of Anti-glomerular Basement Membrane Disease Using a Newly Developed Chemiluminescence Immunoassay
por: Kühnl, Alexander, et al.
Publicado: (2022)